Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment.
Quevedo, C.E., Cruz-Migoni, A., Bery, N., Miller, A., Tanaka, T., Petch, D., Bataille, C.J.R., Lee, L.Y.W., Fallon, P.S., Tulmin, H., Ehebauer, M.T., Fernandez-Fuentes, N., Russell, A.J., Carr, S.B., Phillips, S.E.V., Rabbitts, T.H.(2018) Nat Commun 9: 3169-3169
- PubMed: 30093669 
- DOI: 10.1038/s41467-018-05707-2
- Primary Citation of Related Structures:  
6FA2, 6FA1, 6FA4, 6FA3, 5OCG, 5OCT, 5OCO - PubMed Abstract: 
Targeting specific protein-protein interactions (PPIs) is an attractive concept for drug development, but hard to implement since intracellular antibodies do not penetrate cells and most small-molecule drugs are considered unsuitable for PPI inhibition ...